U.S. Tick Risks Shift as 476,000 Lyme Cases a Year Highlight Expanding Threat

Q: A Lyme disease vaccine is in final trials. When will this crucial prevention tool finally be publicly available?

The earliest likely public availability is 2027, assuming regulators approve it on schedule. The Lyme vaccine in late-stage testing, VLA15, is being developed by Pfizer and Valneva. The companies have said they plan to file for approval in the United States and Europe in 2026 after Phase 3 trial results. If the Food and Drug Administration clears it, the Centers for Disease Control and Prevention and its advisory panel would then decide how it should be used in the U.S. That means 2027 is the practical target for rollout, not a guaranteed launch date. Availability still depends on regulatory review, manufacturing, and public-health recommendations after approval. The vaccine matters because Lyme disease risk is rising as blacklegged ticks spread into more areas. The CDC estimates roughly 476,000 people in the United States are treated for Lyme disease each year, and cases of other blacklegged tick illnesses, including babesiosis and Powassan virus, are also increasing. Early reporting on the trial has been encouraging, with protection estimates around 70% to 75% versus placebo. But some experts have cautioned that regulators will closely examine the full data package before deciding, and additional study could still be requested. So the short answer is that a Lyme vaccine could reach the public in 2027, but only if the current review process goes smoothly.

2 articles · Updated · The New York Times · Jul 10

476,000 people are treated for Lyme disease nationwide each year, as experts warn tick-borne risks are shifting across the U.S. rather than staying confined to traditional hotspots.
Booming white-tailed deer populations, changing land use and rising temperatures are helping different tick species spread into new areas, including places closer to suburbs and cities.
The Northeast still faces its highest threat from blacklegged ticks and Lyme disease, with emergency-room visit rates for tick bites already highest there and reported Lyme cases rising in states including Vermont and New York.
That same region is also seeing more illnesses carried by blacklegged ticks beyond Lyme, including babesiosis and the rare Powassan virus, underscoring how familiar tick zones are adding new health risks.